Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
Abstract To study the role of cell softening in malignant progression, Transwell assay and atomic force microscope were used to classify six human non-small cell lung cancer cell lines into two groups: a high motility-low stiffness (HMLS) group and a low motility-high stiffness (LMHS) group. We foun...
Guardado en:
Autores principales: | Keisuke Iida, Ryo Sakai, Shota Yokoyama, Naritaka Kobayashi, Shodai Togo, Hiroshi Y. Yoshikawa, Anchalee Rawangkan, Kozue Namiki, Masami Suganuma |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a557dc64c7504b61bb974bc013633a1e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
AXL receptor tyrosine kinase as a therapeutic target in NSCLC
por: Okimoto RA, et al.
Publicado: (2015) -
Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
por: Andrea Pontara, et al.
Publicado: (2020) -
Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks
por: Yi Wang, et al.
Publicado: (2021) -
Corosolic Acid Attenuates the Invasiveness of Glioblastoma Cells by Promoting CHIP-Mediated AXL Degradation and Inhibiting GAS6/AXL/JAK Axis
por: Li-Wei Sun, et al.
Publicado: (2021) -
Targeting AXL in NSCLC
por: Zaman A, et al.
Publicado: (2021)